Venn Life Sciences (LON:VENN) Stock Price Crosses Above 50-Day Moving Average of $6.85

Venn Life Sciences Holdings PLC (LON:VENN) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares.

Venn Life Sciences Stock Performance

The business has a fifty day moving average of GBX 6.85 and a 200-day moving average of GBX 6.85. The company has a market cap of £4.89 million and a PE ratio of -2.14. The company has a current ratio of 2.30, a quick ratio of 1.48 and a debt-to-equity ratio of 35.83.

Venn Life Sciences Company Profile

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.